C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2009
12/17/2009	CA2724919A1 Angiotensin ii receptor antagonists
12/16/2009	EP2133348A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
12/16/2009	EP2133347A1 1-biarylazetidinone derivatives
12/16/2009	EP2133340A1 Novel benzazepine derivatives
12/16/2009	EP2133331A1 5-membered heterocyclic derivative and use thereof for medical purposes
12/16/2009	EP2133077A1 Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv
12/16/2009	EP2132200A2 Nitro-imidazole hypoxia imaging agents
12/16/2009	EP2132199A1 Substituted pyrimidines
12/16/2009	EP2132197A2 Substituted pyrimidines as adenosine receptor antagonists
12/16/2009	EP2131656A2 Phthalazine derivatives
12/16/2009	EP1805165B1 1-(hetero)aryl-3-amino-pyrrolidine derivatives for use as mglur3 receptor antagonists
12/16/2009	EP1778684B1 4-PIPERAZINYL-PYRIMIDINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D<sb>3</sb> RECEPTOR
12/16/2009	EP1576159B9 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
12/16/2009	EP1390029B1 Phenylindoles for the treatment of hiv
12/16/2009	CN101605783A New N, N'- 2,4-dianilinopyrimidine derivatives, preparation thereof as drugs, pharmaceutical compositions essentially as ikk inhibitors
12/16/2009	CN101605779A Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
12/16/2009	CN101605767A Process for the preparation of piperazinyl and diazepanyl benzamide derivatives
12/16/2009	CN101605766A Pyrimidines derivatives and their use as kinase inhibitors
12/16/2009	CN101605758A Methods for treating hepatitis C
12/16/2009	CN101602760A Method for preparing olmesartan medoxomil
12/16/2009	CN101602759A Pyrrole group-containing compound and preparation method and application thereof
12/16/2009	CN101602758A Process for preparing intermediate compound for synthesizing an antiulcerant
12/16/2009	CN101602731A Metalloproteinase inhibitors
12/16/2009	CN101602703A Pyrrole group-containing compound and preparation method and application thereof
12/16/2009	CN100569769C Compounds with antibacterial activity
12/15/2009	US7632857 Histamine H3 receptor agents, preparation and therapeutic uses
12/15/2009	US7632849 Indazolamides with analgesic activity
12/15/2009	US7632840 Quinazoline compounds for the treatment of hyperproliferative disorders
12/15/2009	CA2607940C Bir domain binding compounds
12/15/2009	CA2529611C Pyrimidine derivatives for the treatment of abnormal cell growth
12/15/2009	CA2450567C High molecular weight hydroxyphenylbenzotriazole uv-absorbers for thin film applications
12/15/2009	CA2388320C N-substituted carbamoyloxyalkyl-azolium derivatives
12/15/2009	CA2338000C Water-soluble 4-thio-maleimido derivatives and methods for their production
12/15/2009	CA2267175C Alpha-9 integrin antagonists and anti-inflammatory compositions thereof
12/10/2009	WO2009147843A1 Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof
12/10/2009	WO2009147189A1 Novel compounds
12/10/2009	WO2009147121A1 Carboxyl substituted indoles for use as ppar alpha modulators
12/10/2009	WO2009146648A1 Amide compounds, preparation methods and uses thereof
12/10/2009	WO2009146608A1 Pharmaceutical compositions containing imidazole-5-carboxylic acid derivatives and preparation method and use thereof
12/10/2009	WO2009127642A3 Use of lrrk2 inhibitors for neurodegenerative diseases
12/10/2009	WO2009095163A3 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
12/10/2009	WO2008146172A3 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/10/2009	WO2008135830A8 N- [6-amino-5- (phenyl) pyrazin-2-yl] -isoxazole-4-carboxamide derivatives and related compounds as nav1.8 channel modulators for the treatment of pain
12/10/2009	US20090306396 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
12/10/2009	US20090306376 Optical recording medium and compound used for the same
12/10/2009	US20090306134 Muscarinic receptor antagonists
12/10/2009	US20090306127 Certain Chemical Entities, Compositions and Methods
12/10/2009	US20090306124 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors
12/10/2009	US20090306110 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
12/10/2009	US20090306108 Substituted pyrimidinones
12/10/2009	US20090306090 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
12/10/2009	US20090306070 Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use
12/10/2009	US20090306052 Indenyl derivatives and use thereof for the treatment of neurological disorders
12/10/2009	US20090306047 Heterocyclic aspartyl protease inhibitors
12/10/2009	US20090306044 Quinazoline derivatives for the treatment of cancer diseases
12/10/2009	US20090306039 Compounds and compositions as itpkb inhibitors
12/10/2009	US20090306038 2-Aminopyrimidine derivatives as modulators of the histamine H4 receptor activity
12/10/2009	US20090305410 Fluorescent compounds
12/10/2009	US20090304631 Hepatitis c serine protease inhibitors and uses therefor
12/10/2009	US20090304583 Pathological tissue detection and treatment employing targeted benzoindole optical agents
12/10/2009	US20090302752 Carbazole derivatives for organic electroluminescent devices
12/10/2009	CA2726579A1 Novel uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity
12/09/2009	EP2130822A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
12/09/2009	EP2130820A1 Antipruritics
12/09/2009	EP2130541A2 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
12/09/2009	EP2130537A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/09/2009	EP2130536A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/09/2009	EP2129666A2 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry
12/09/2009	EP1871765B1 3-(indazol-5-yl)-(1,2,4)triazine derivatives and related compounds as protein kinase inhibitors for the treatment of cancer
12/09/2009	EP1745040B1 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
12/09/2009	EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/09/2009	EP1020179B1 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
12/09/2009	CN101600711A Azetidine analogues of nucleosidase and phosphorylase inhibitors
12/09/2009	CN101600706A Akt活性抑制剂 Akt activity inhibitor
12/09/2009	CN101600696A Substituted arylpyrazoles
12/09/2009	CN101600693A Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases
12/09/2009	CN101597262A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/09/2009	CN100567293C N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
12/09/2009	CN100567266C Cannabinoid receptor ligands
12/09/2009	CN100567265C Organometallic complexes and organic electroluminescence device using the same
12/08/2009	US7629463 Pesticides that are more effective, less costly, less toxic, environmentally safer; 1-(2-chloromethyl-N-[2-methyl-6-(1-methyl-1H-imidazol-2-yl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide
12/08/2009	US7629377 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders
12/08/2009	US7629374 Use of aminoindazole derivatives for the inhibition of tau phosphorylation
12/08/2009	US7629357 Antihypoxic agents; adjust concentration of erythropoietin concentration in blood; strokes; antiepileptic agents; neurodegenerative disease ; liver disorders; antiischemic agents
12/08/2009	US7629343 Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors
12/08/2009	US7629340 N-(6-membered aromatic ring)-amido anti-viral compounds
12/08/2009	CA2422354C Pyrazole compounds useful as protein kinase inhibitors
12/08/2009	CA2415486C Pyramidine derivatives
12/08/2009	CA2398794C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
12/08/2009	CA2374898C Pyrazinyl-piperazine compounds, their use and preparation
12/03/2009	WO2009145856A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
12/03/2009	WO2009145829A1 Type iii secretion inhibitors, analogs and uses thereof
12/03/2009	WO2009145814A2 Pyrimidines and pyridines useful as inhibitors of protein kinases
12/03/2009	WO2009145721A1 Isoindoline derivatives comprising phenyl groups and their use in the treatment of pain disorders
12/03/2009	WO2009145718A1 Isoindoline derivatives comprising an additional heterocyclic group and their use in the treatment of pain disorders
12/03/2009	WO2009145591A2 Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof
12/03/2009	WO2009145357A1 In 1-position durch einen ring substituierte benzo [1, 4] diazepine zur verwendungs als antidepressiva
12/03/2009	WO2009144961A1 Substituted carbinol compound having cyclic linker
12/03/2009	WO2009126672A3 2-alkynyl-6-pyridin-2-yl-pyridazinones, 2-alkynyl-6-pyridin-2-yl-dihydropyridazinones, 2-alkynyl-6-pyrimidin-2-yl-pyridazinones and 2-alkynyl-6-pyrimidin-2-yl-dihydropyridazinones and their use as fungicides
12/03/2009	WO2009122034A3 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof

1 ... 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 ... 626